October 31, 2012
First Partner Assay on the BD MAX™ System Launches in Europe
|
October 12, 2012
BD and Lab21 Collaborate to Develop New Oncology Assays on the BD MAX™ Platform
|
August 14, 2012
New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug
|
July 09, 2012
New, Fully Automated BD MAX™ MRSA Assay Rapidly Identifies Patients Colonized with Deadly Superbug
|
August 18, 2011
BD Diagnostics and Biodiversity Collaborate to Develop Portfolio of Assays on the BD MAX™ System
|
August 03, 2011
BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX™ Molecular Testing System
|
July 06, 2011
BD Diagnostics Hires Leading Infectious Disease Diagnostics Expert to Strengthen New Product Pipeline
|
May 19, 2011
BD Launches BD MAX™ System in U.S. to Empower Laboratories and Clinicians to Respond to Emerging Diseases
|
May 09, 2011
BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System
|
May 08, 2011
Bruker Announces Integrated Microbiology Workflow For MALDI Biotyper Microbial Identification and BD Phoenix™ Antibiotic Susceptibility Testing
|
May 06, 2011
BD Launches BD MAX™ Open System in Europe and Reveals Strategy to Build Broad Menu of Assays that Provide Timely, Accurate Information to Laboratories and Clinicians
|
April 19, 2011
"VBP (Value-based purchasing) will reward HAI reduction," written by Kathy Warye, VP, Infection Prevention, appears in Medical Laboratory Observer's Washington Report April 2011 issue
|
April 07, 2011
World Health Day Emphasis on Antimicrobial Resistance Brings Much-Needed Awareness to Alarming Issue
|
April 04, 2011
New CDC Guidelines Recognize Value of Split Septum IV Access Technology to Reduce Intravascular Catheter-Related Bloodstream Infections
|
November 16, 2010
BD Taps Leading Voice in Infection Prevention Community to Advance Efforts to Reduce Healthcare-Associated Infections
|
October 25, 2010
BD Diagnostics and Lonza Collaborate to Commercialize the Lonza microCompass™ Molecular Assays on the BD MAX™ System
|
September 29, 2010
BD Diagnostics and Bruker Collaborate to Improve Microbial Identification and Antimicrobial Susceptibility Testing
|
August 03, 2010
BD Receives CLIA "Moderate Complexity" Status for the BD MAX™ GBS Assay
|
July 13, 2010
Study Shows Universal Surveillance for MRSA Significantly Decreased Healthcare-Associated Infections at Pitt County Memorial Hospital
|
June 02, 2010
BD Announces First FDA-Cleared Assay on the BD MAX™ System to Detect Group B Streptococcus
|
March 18, 2010
BD Diagnostics Launches the BD Protect™ Infection Surveillance and Prevention Software Portfolio
|
December 24, 2009
BD GeneOhm™ MRSA ACP Assay Results in Fewer Steps and Less Hands-On Time for Lab Workers
|
October 23, 2009
BD Announces Agreement to Acquire HandyLab, Inc.
|
August 06, 2009
BD Adds Surveillance Capability to Infectious Disease Portfolio
|
August 05, 2009
APIC Announces Launch of Online Education Center for Instant Access to Comprehensive Infection Prevention
|
May 18, 2009
BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays
|
March 25, 2009
BD Announces Health Canada Licensing of Novel Molecular Assay for the Detection of Vancomycin Resistance Genes
|
January 12, 2009
BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
|
December 17, 2008
BD Selected to Participate in Premier QUEST Nationwide Hospital Collaborative to Reduce Healthcare-Associated Infections
|
November 20, 2008
BD Announces Health Canada Licensing of Novel Molecular Assay for Detection of Clostridium difficile Toxin B Gene
|
July 07, 2008
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections
|
June 10, 2008
BD Celebrates Opening of New Manufacturing Center in Québec
|
June 02, 2008
New BD BACTEC™ FX Blood Culture Instrument with the BD EpiCenter™ Operating System can Facilitate Fast and Effective Clinical Decisions for Patients with Bacterial Infections
|
April 07, 2008
Preliminary Data from Pitt County Memorial Hospital Study Show Benefit of Active Surveillance on Reducing MRSA VAP Rates in Surgical ICU
|
March 17, 2008
BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates
|
January 02, 2008
BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
|
December 20, 2007
BD Announces CE Marking of Rapid Molecular Test to Identify Superbug from Nasal and Wound Specimens
|
December 18, 2007
UCLH Study Demonstrates Rapid Patient Screening Could Cut MRSA Rates By Almost 40 Per Cent
|
November 05, 2007
BD Sponsors New Tool to Combat MRSA Infections in Hospitals
|
October 22, 2007
CEO Ed Ludwig Discusses Healthcare-associated Infections on CNBC (Video)
|
October 04, 2007
Screening for Nasal Carriage of MRSA: Reduction of Turnaround Time and Workload by the use of BD BBL™ CHROMagar™ MRSA
|
September 12, 2007
BD GeneOhm's Flagship Client, Evanston Northwestern Healthcare, Receives Prestigious Patient Safety Award from the NQF and the Joint Commission for its MRSA Prevention Program
|
June 25, 2007
APIC Announces MRSA Prevalence Study Results
|
May 23, 2007
BD Demonstrates Microbiology Automation Designed to Improve Laboratory Efficiency of Microbial Identification and Susceptibility Testing
|
May 21, 2007
BD Receives CE Mark Approval for Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
|
May 21, 2007
BD Receives CE Mark Approval for Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
|
April 25, 2007
BD Announces FDA 510(k) Submission of Two Hour Test to Identify Superbug in Patients with Positive Blood Cultures
|
February 09, 2007
BD Helping APIC to Expand its Mission in HAIs Prevention at the APIC Futures Summit (PDF)
|
December 01, 2006
Evanston Northwestern Healthcare Study Shows Benefit of Universal Surveillance (PDF)
|
December 01, 2006
Evanston Northwestern Healthcare Study Reveals Who is Most at Risk for Carrying MRSA (PDF)
|
December 01, 2006
"Grand Rounds" Address Impact of Antibiotic-Resistant Superbug on Healthcare Facilities (PDF)
|
